| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |